GSK
GSK
GSK
846 hedge funds and large institutions have $11.7B invested in GSK in 2019 Q1 according to their latest regulatory filings, with 112 funds opening new positions, 313 increasing their positions, 263 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 798 → 846 (+48)
0.07% more ownership
Funds ownership: 4.45% → 4.52% (+0.07%)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
Holders
846
Holding in Top 10
14
Calls
$178M
Puts
$67.7M
Top Buyers
| 1 | +$127M | |
| 2 | +$105M | |
| 3 | +$68.6M | |
| 4 |
Two Sigma Investments
New York
|
+$38.1M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$32.8M |
Top Sellers
| 1 | -$226M | |
| 2 | -$76.4M | |
| 3 | -$49.3M | |
| 4 |
Jane Street
New York
|
-$45M |
| 5 |
WIC
Willis Investment Counsel
Gainesville,
Georgia
|
-$18M |